{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:10:40Z","timestamp":1793045440667,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jhep.2013.05.030","type":"journal-article","created":{"date-parts":[[2013,5,25]],"date-time":"2013-05-25T14:17:26Z","timestamp":1369491446000},"page":"842-858","source":"Crossref","is-referenced-by-count":202,"title":["The metabolomic window into hepatobiliary disease"],"prefix":"10.1016","volume":"59","author":[{"given":"Diren","family":"Beyo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Idle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.05.030_b0005","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cmet.2007.10.005","article-title":"Metabolomics","volume":"6","author":"Idle","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2013.05.030_b0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic prognostic and therapeutic implications","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhep.2013.05.030_b0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cgh.2012.03.011","article-title":"Features, diagnosis, and treatment of non-alcoholic fatty liver disease","volume":"10","author":"Torres","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.05.030_b0020","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/pr901203w","article-title":"Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease","volume":"9","author":"Vinaixa","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbalip.2007.07.007","article-title":"Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis","volume":"1771","author":"van Ginneken","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2013.05.030_b0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/CS20090169","article-title":"Delivery by Caesarean section, rather than vaginal delivery, promotes hepatic steatosis in piglets","volume":"118","author":"Hyde","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhep.2013.05.030_b0035","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of non-alcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.05.030_b0040","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1021\/pr200629p","article-title":"A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations","volume":"10","author":"Garcia-Canaveras","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in non-alcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2013.05.030_b0050","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/pr1002593","article-title":"Liquid chromatography\u2013mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of non-alcoholic fatty liver disease","volume":"9","author":"Barr","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0055","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1021\/pr200047c","article-title":"A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in non-alcoholic fatty liver disease","volume":"10","author":"Li","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0060","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-007-0738-5","article-title":"Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice","volume":"50","author":"Toye","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2013.05.030_b0065","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1039\/c0mb00309c","article-title":"Tracking cellular metabolomics in lipoapoptosis- and steatosis-developing liver cells","volume":"7","author":"Noguchi","year":"2011","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.jhep.2013.05.030_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/pr0601640","article-title":"The influence of pharmacogenetics on fatty liver disease in the Wistar and Kyoto rats: a combined transcriptomic and metabonomic study","volume":"6","author":"Griffin","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0075","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.ajpath.2011.08.014","article-title":"Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in AxB mice","volume":"179","author":"Hines","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2013.05.030_b0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1751-2980.2009.00369.x","article-title":"Bile acids and insulin resistance: implications for treating non-alcoholic fatty liver disease","volume":"10","author":"Wei","year":"2009","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jhep.2013.05.030_b0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2013.05.030_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-8-8","article-title":"Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice","volume":"8","author":"Stanton","year":"2011","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jhep.2013.05.030_b0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2012.08.013","article-title":"Metabolomics and its potential in drug development","volume":"85","author":"Beyoglu","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2013.05.030_b0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with non-alcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.05.030_b0105","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1074\/jbc.M710422200","article-title":"Identification and characterization of a major liver lysophosphatidylcholine acyltransferase","volume":"283","author":"Zhao","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.05.030_b0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.taap.2006.10.007","article-title":"Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats","volume":"218","author":"Constantinou","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2013.05.030_b0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/RTPM1PY6YGBL2G2R","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"128","author":"Yeh","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jhep.2013.05.030_b0120","first-page":"85","article-title":"The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis","volume":"110","author":"Wiegand","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jhep.2013.05.030_b0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpba.2012.09.021","article-title":"Urinary metabonomics characterization of liver fibrosis induced by CCl(4) in rats and intervention effects of Xia Yu Xue Decoction","volume":"74","author":"Gou","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jhep.2013.05.030_b0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1039\/C2AN36382H","article-title":"Metabolomics study on the hepatoprotective effect of scoparone using ultra-performance liquid chromatography\/electrospray ionization quadruple time-of-flight mass spectrometry","volume":"138","author":"Zhang","year":"2013","journal-title":"Analyst"},{"key":"10.1016\/j.jhep.2013.05.030_b0135","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1349-7006.2009.01086.x","article-title":"Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis","volume":"100","author":"Gao","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0140","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1016\/j.chroma.2011.05.039","article-title":"Improved enantiomer resolution and quantification of free d-amino acids in serum and urine by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry","volume":"1218","author":"Waldhier","year":"2011","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jhep.2013.05.030_b0145","first-page":"1367","article-title":"A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry","volume":"124","author":"Lian","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jhep.2013.05.030_b0150","first-page":"314","article-title":"Application of liquid chromatography\u2013mass spectrometry in the study of metabolic profiling of cirrhosis in different grades","volume":"29","author":"Du","year":"2011","journal-title":"Se Pu"},{"key":"10.1016\/j.jhep.2013.05.030_b0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3748\/wjg.v18.i3.285","article-title":"(1)H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis","volume":"18","author":"Qi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.05.030_b0160","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/jssc.201100408","article-title":"Classification and differential metabolite discovery of liver diseases based on plasma metabolic profiling and support vector machines","volume":"34","author":"Lin","year":"2011","journal-title":"J Sep Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0165","first-page":"111","article-title":"Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies","volume":"27","author":"Martinez-Granados","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jhep.2013.05.030_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2013.01.001","article-title":"Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients","author":"Huang","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2013.05.030_b0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1574-6968.2009.01531.x","article-title":"Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces","volume":"293","author":"Fukiya","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jhep.2013.05.030_b0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchromb.2004.09.032","article-title":"Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases","volume":"813","author":"Yang","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0185","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.chroma.2004.10.100","article-title":"Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry","volume":"1084","author":"Yang","year":"2005","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jhep.2013.05.030_b0190","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1021\/pr070063h","article-title":"Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis","volume":"6","author":"Yang","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0195","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1039\/b820224a","article-title":"A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry","volume":"5","author":"Yin","year":"2009","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.jhep.2013.05.030_b0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.aca.2009.06.033","article-title":"Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography\/mass spectrometry","volume":"648","author":"Wu","year":"2009","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.jhep.2013.05.030_b0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.aca.2009.03.039","article-title":"Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations","volume":"650","author":"Chen","year":"2009","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.jhep.2013.05.030_b0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13277-010-0116-7","article-title":"(1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis","volume":"32","author":"Wang","year":"2011","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jhep.2013.05.030_b0215","article-title":"Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma","volume":"5","author":"Chen","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jhep.2013.05.030_b0220","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00216-011-5245-3","article-title":"Identification of serum biomarkers of hepatocarcinoma through liquid chromatography\/mass spectrometry-based metabonomic method","volume":"401","author":"Chen","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jhep.2013.05.030_b0225","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/0008-5472.CAN-11-0885","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling","volume":"71","author":"Patterson","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0230","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010694","article-title":"Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis","volume":"11","author":"Tan","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jhep.2013.05.030_b0235","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1021\/pr2009252","article-title":"Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography\u2013mass spectrometry","volume":"11","author":"Wang","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00216-012-5782-4","article-title":"Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases","volume":"403","author":"Zhou","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jhep.2013.05.030_b0245","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1021\/pr300502v","article-title":"Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography\u2013mass spectrometry","volume":"11","author":"Ye","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jchromb.2012.05.020","article-title":"A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information","volume":"910","author":"Lin","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.aca.2012.07.013","article-title":"Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis","volume":"743","author":"Ressom","year":"2012","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.jhep.2013.05.030_b0260","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1021\/pr300673x","article-title":"LC\u2013MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort","volume":"11","author":"Xiao","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cca.2012.12.024","article-title":"Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry","volume":"418","author":"Zhang","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jhep.2013.05.030_b0270","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1158\/1078-0432.CCR-12-1099","article-title":"Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis","volume":"18","author":"Nahon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0275","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.01.054","article-title":"Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes","author":"Budhu","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.05.030_b0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.26350","article-title":"Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification","volume":"58","author":"Beyoglu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.05.030_b0285","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/pr101096f","article-title":"Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study","volume":"10","author":"Shariff","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0290","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/rcm.4703","article-title":"Gas chromatography\/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis","volume":"24","author":"Li","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.jhep.2013.05.030_b0295","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1021\/pr800353t","article-title":"Metabolic changes in flatfish hepatic tumours revealed by NMR-based metabolomics and metabolic correlation networks","volume":"7","author":"Southam","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/omi.2005.9.281","article-title":"Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study","volume":"9","author":"Stentiford","year":"2005","journal-title":"OMICS"},{"key":"10.1016\/j.jhep.2013.05.030_b0305","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1440-1746.2006.04640.x","article-title":"Role of mitochondria in non-alcoholic fatty liver disease","volume":"22","author":"Pessayre","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.05.030_b0310","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.metabol.2012.07.007","article-title":"Ammonium metabolism in humans","volume":"61","author":"Adeva","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2013.05.030_b0315","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-011-9269-3","article-title":"Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy","volume":"27","author":"Felipo","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2013.05.030_b0320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12291-010-0007-0","article-title":"Role of plasma amino acids and gaba in alcoholic and non-alcoholic fatty liver disease-a pilot study","volume":"25","author":"Mukherjee","year":"2010","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.jhep.2013.05.030_b0325","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","article-title":"Minireview: 11beta-hydroxysteroid dehydrogenase type 1 \u2013 a tissue-specific amplifier of glucocorticoid action","volume":"142","author":"Seckl","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2013.05.030_b0330","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1210\/jc.2009-1412","article-title":"11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus\u2013pituitary\u2013adrenal axis, metabolic syndrome, and inflammation","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhep.2013.05.030_b0335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.diabres.2012.12.020","article-title":"Association of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms with serum alanine aminotransferase activity","volume":"99","author":"Moon","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jhep.2013.05.030_b0340","first-page":"1853","article-title":"Amino acid metabolism in liver diseases","volume":"81","author":"Muting","year":"1956","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jhep.2013.05.030_b0345","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11011-013-9377-3","article-title":"Branched-chain amino acids and muscle ammonia detoxification in cirrhosis","volume":"28","author":"Dam","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2013.05.030_b0350","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.05.030_b0355","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2013.05.030_b0360","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.05.030_b0365","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1530-0277.2008.00892.x","article-title":"Quantitative lipid metabolomic changes in alcoholic micropigs with fatty liver disease","volume":"33","author":"Zivkovic","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0370","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jchromb.2011.06.018","article-title":"Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice","volume":"879","author":"Li","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0375","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.taap.2011.05.022","article-title":"Lipidomic changes in rat liver after long-term exposure to ethanol","volume":"255","author":"Fernando","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2013.05.030_b0380","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1021\/pr9004103","article-title":"Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation","volume":"8","author":"Patterson","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0385","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/me.2007-0150","article-title":"Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation","volume":"21","author":"Zhen","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2013.05.030_b0390","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1021\/pr100452b","article-title":"Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse","volume":"9","author":"Manna","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0395","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1021\/pr200310s","article-title":"UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model","volume":"10","author":"Manna","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2004.10.005","article-title":"Metabolism of alcohol","volume":"9","author":"Lieber","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2013.05.030_b0405","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1074\/jbc.M111.312199","article-title":"Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis","volume":"287","author":"Shi","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.05.030_b0410","doi-asserted-by":"crossref","first-page":"e1294","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.05.030_b0415","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/pr050364w","article-title":"High performance liquid chromatography\u2013mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B","volume":"5","author":"Yang","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0420","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/abbs\/gmq078","article-title":"Development and validation of a liquid chromatography\u2013mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus","volume":"42","author":"Zhang","year":"2010","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.jhep.2013.05.030_b0425","doi-asserted-by":"crossref","first-page":"25C","DOI":"10.1155\/2007\/729675","article-title":"Management of chronic hepatitis C: consensus guidelines","volume":"21","author":"Sherman","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.05.030_b0430","doi-asserted-by":"crossref","first-page":"5C","DOI":"10.1155\/2007\/728732","article-title":"Management of chronic hepatitis B: consensus guidelines","volume":"21","author":"Sherman","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.05.030_b0435","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.05.030_b0440","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.aca.2009.07.005","article-title":"Pattern recognition of inductively coupled plasma atomic emission spectroscopy of human scalp hair for discriminating between healthy and hepatitis C patients","volume":"649","author":"Lloyd","year":"2009","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.jhep.2013.05.030_b0445","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00216-012-6619-x","article-title":"Metallomics: an emerging interdisciplinary science","volume":"405","author":"Sperling","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jhep.2013.05.030_b0450","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2893.2009.01252.x","article-title":"Hepatitis C virus infection diagnosis using metabonomics","volume":"17","author":"Godoy","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2013.05.030_b0455","doi-asserted-by":"crossref","first-page":"e23641","DOI":"10.1371\/journal.pone.0023641","article-title":"Metabolomic profile of hepatitis C virus-infected hepatocytes","volume":"6","author":"Roe","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.05.030_b0460","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1074\/mcp.M112.019141","article-title":"Metabolomic analysis of key regulatory metabolites in HCV-infected tree shrews","volume":"12","author":"Sun","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jhep.2013.05.030_b0465","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.05.030_b0470","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.05.030_b0475","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.freeradbiomed.2005.07.005","article-title":"Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage","volume":"39","author":"Komichi","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2013.05.030_b0480","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1477-2574.2010.00185.x","article-title":"Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy","volume":"12","author":"Sharif","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2013.05.030_b0485","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1477-2574.2011.00296.x","article-title":"Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma","volume":"13","author":"Hashim Abdalla","year":"2011","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2013.05.030_b0490","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1742-7843.2009.00410.x","article-title":"Identification of urinary biomarkers useful for distinguishing a difference in mechanism of toxicity in rat model of cholestasis","volume":"105","author":"Ishihara","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jhep.2013.05.030_b0495","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1194\/jlr.M002923","article-title":"Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge","volume":"51","author":"Cho","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0500","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/rcm.5072","article-title":"Metabolomic investigation of cholestasis in a rat model using ultra-performance liquid chromatography\/tandem mass spectrometry","volume":"25","author":"Aoki","year":"2011","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.jhep.2013.05.030_b0505","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00011-012-0491-1","article-title":"Metabolomic study of serum from rabbits with acute acalculous cholecystitis","volume":"61","author":"Li","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0510","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.tp.0000251649.01148.f8","article-title":"Early detection of graft failure using the blood metabolic profile of a liver recipient","volume":"83","author":"Serkova","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.05.030_b0515","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1039\/c2mt20017a","article-title":"A systems approach implicates nuclear receptor targeting in the Atp7b(\u2212\/\u2212) mouse model of Wilson\u2019s disease","volume":"4","author":"Wilmarth","year":"2012","journal-title":"Metallomics"},{"key":"10.1016\/j.jhep.2013.05.030_b0520","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/es902558k","article-title":"Identifying health impacts of exposure to copper using transcriptomics and metabolomics in a fish model","volume":"44","author":"Santos","year":"2010","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhep.2013.05.030_b0525","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2013.05.030_b0530","doi-asserted-by":"crossref","first-page":"901854","DOI":"10.1155\/2011\/901854","article-title":"Liver metabolic alterations and changes in host intercompartmental metabolic correlation during progression of malaria","volume":"2011","author":"Sengupta","year":"2011","journal-title":"J Parasitol Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0535","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/1475-2875-10-384","article-title":"Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study","volume":"10","author":"Sengupta","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.jhep.2013.05.030_b0540","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1021\/pr300562m","article-title":"Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a (1)H NMR spectroscopy-based metabonomic study","volume":"11","author":"Ghosh","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0545","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1478-3231.2008.01801.x","article-title":"A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats","volume":"28","author":"Barba","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.05.030_b0550","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1478-3231.2008.01817.x","article-title":"Metabonomics in hepatic encephalopathy: lucidity emerging from confusion","volume":"28","author":"Williams","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.05.030_b0555","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1021\/pr100486e","article-title":"Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance","volume":"9","author":"Jimenez","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0560","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-012-9303-0","article-title":"A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy","volume":"27","author":"Bajaj","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2013.05.030_b0565","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/toxsci\/57.2.326","article-title":"Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants","volume":"57","author":"Robertson","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0570","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"Nicholson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2013.05.030_b0575","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ab.2003.07.026","article-title":"Spectral editing and pattern recognition methods applied to high-resolution magic-angle spinning 1H nuclear magnetic resonance spectroscopy of liver tissues","volume":"323","author":"Wang","year":"2003","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jhep.2013.05.030_b0580","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.toxlet.2003.09.011","article-title":"Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity","volume":"146","author":"Harrigan","year":"2004","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jhep.2013.05.030_b0585","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.taap.2004.06.031","article-title":"Comparative metabonomics of differential hydrazine toxicity in the rat and mouse","volume":"204","author":"Bollard","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2013.05.030_b0590","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/01926230590958146","article-title":"Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis","volume":"33","author":"Heijne","year":"2005","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jhep.2013.05.030_b0595","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/pr060024q","article-title":"Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis","volume":"5","author":"Waters","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0600","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1021\/pr0503376","article-title":"Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat","volume":"5","author":"Craig","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0605","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1742-7843.2006.pto_455.x","article-title":"A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats","volume":"99","author":"Ishihara","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jhep.2013.05.030_b0610","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-230X-9-99","article-title":"A novel scoring system for prognostic prediction in d-galactosamine\/lipopolysaccharide-induced fulminant hepatic failure BALB\/c mice","volume":"9","author":"Feng","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2013.05.030_b0615","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1021\/pr201161f","article-title":"Pharmacometabonomic investigation of dynamic metabolic phenotypes associated with variability in response to galactosamine hepatotoxicity","volume":"11","author":"Coen","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0620","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1021\/pr0601584","article-title":"An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate","volume":"5","author":"Yap","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0625","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.toxlet.2007.07.010","article-title":"NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats","volume":"173","author":"Shi","year":"2007","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jhep.2013.05.030_b0630","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jchromb.2008.04.008","article-title":"Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC\/MS","volume":"871","author":"Sun","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0635","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/tx800464q","article-title":"Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity","volume":"22","author":"Chen","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jhep.2013.05.030_b0640","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1124\/dmd.109.027565","article-title":"Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity","volume":"37","author":"Cheng","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2013.05.030_b0645","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2009.240","article-title":"Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans","volume":"88","author":"Winnike","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2013.05.030_b0650","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2133\/dmpk.DMPK-11-RG-005","article-title":"A 1H NMR-based metabolomics approach for mechanistic insight into acetaminophen-induced hepatotoxicity","volume":"26","author":"Fukuhara","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jhep.2013.05.030_b0655","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jat.1746","article-title":"Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics","volume":"32","author":"Kumar","year":"2012","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.jhep.2013.05.030_b0660","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.taap.2011.12.017","article-title":"Predictive toxicology using systemic biology and liver microfluidic \u201con chip\u201d approaches: application to acetaminophen injury","volume":"259","author":"Prot","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2013.05.030_b0665","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1021\/ac2011075","article-title":"Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs","volume":"84","author":"Shintu","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.jhep.2013.05.030_b0670","first-page":"730","article-title":"Metabonomics profile of urine from rats administrated with different treatment period of isoniazid","volume":"29","author":"Liao","year":"2007","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.jhep.2013.05.030_b0675","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm.3104","article-title":"Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy","volume":"19","author":"Li","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2013.05.030_b0680","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jchromb.2008.05.049","article-title":"A metabonomic characterization of CCl4-induced acute liver failure using partial least square regression based on the GC\/MS metabolic profiles of plasma in mice","volume":"870","author":"Huang","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0685","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/tx800225q","article-title":"Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography\u2013mass spectrometry","volume":"21","author":"Yang","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jhep.2013.05.030_b0690","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tox.2008.11.018","article-title":"An integrated metabonomic method for profiling of metabolic changes in carbon tetrachloride induced rat urine","volume":"256","author":"Lin","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.jhep.2013.05.030_b0695","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1021\/pr9000256","article-title":"Systems biological responses to chronic perfluorododecanoic acid exposure by integrated metabonomic and transcriptomic studies","volume":"8","author":"Ding","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0700","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/1091581809340329","article-title":"Metabolomics study with gas chromatography\u2013mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine","volume":"28","author":"Lee","year":"2009","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.jhep.2013.05.030_b0705","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpba.2009.12.026","article-title":"Metabonomics study of urine from Sprague\u2013Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy","volume":"52","author":"Liu","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jhep.2013.05.030_b0710","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpba.2010.03.015","article-title":"Metabonomics study of the protective effects of Lonicera japonica extract on acute liver injury in dimethylnitrosamine treated rats","volume":"53","author":"Sun","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jhep.2013.05.030_b0715","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.taap.2010.07.020","article-title":"NMR-based metabonomic analysis of the hepatotoxicity induced by combined exposure to PCBs and TCDD in rats","volume":"248","author":"Lu","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2013.05.030_b0720","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1021\/pr300297z","article-title":"Metabolomic analysis of the effects of polychlorinated biphenyls in non-alcoholic fatty liver disease","volume":"11","author":"Shi","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2013.05.030_b0725","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tox.2011.05.012","article-title":"Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat","volume":"287","author":"Shima","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.jhep.2013.05.030_b0730","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1091581811414436","article-title":"A metabonomic characterization of (+)-usnic acid-induced liver injury by gas chromatography\u2013mass spectrometry-based metabolic profiling of the plasma and liver in rat","volume":"30","author":"Lu","year":"2011","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.jhep.2013.05.030_b0735","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/toxsci\/kfr238","article-title":"Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity","volume":"124","author":"Parman","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2013.05.030_b0740","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0192623308329287","article-title":"The liver toxicity biomarker study: phase I design and preliminary results","volume":"37","author":"McBurney","year":"2009","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jhep.2013.05.030_b0745","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0029-1240008","article-title":"Biomarkers for the diagnosis and management of drug-induced liver injury","volume":"29","author":"Watkins","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2013.05.030_b0750","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.taap.2009.11.019","article-title":"Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity","volume":"243","author":"Beger","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2013.05.030_b0755","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/clpt.2010.151","article-title":"The application of metabonomics to predict drug-induced liver injury","volume":"88","author":"O\u2019Connell","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2013.05.030_b0760","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.taap.2010.09.022","article-title":"The enhanced value of combining conventional and \u201comics\u201d analyses in early assessment of drug-induced hepatobiliary injury","volume":"252","author":"Ellinger-Ziegelbauer","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2013.05.030_b0765","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s11306-011-0329-9","article-title":"Serum UPLC\u2013MS\/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity","volume":"8","author":"Gonzalez","year":"2012","journal-title":"Metabolomics"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813003620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813003620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T22:25:10Z","timestamp":1645568710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813003620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0168827813003620"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.05.030","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}